Moreover, CD276 level was significantly associated with tumor immune cell infiltration, biomarkers of immune cells, and immune checkpoint expression.<h4>Conclusions</h4>Our analyses indicated that increased CD276 may contribute to colon adenocarcinoma development by activating tumor-promoting signal pathways and altering the immune microenvironment. The gene discussed is CD276; the disease is colon adenocarcinoma.